| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/28/2004 | US20040214198 Allele-targeted RNA interference |
| 10/28/2004 | US20040214191 Nucleotide sequences coding ganosine triphosphatase ligand for use in diagnosis and treatment of cell proliferative disorders |
| 10/28/2004 | US20040214188 Diagnosis and treatment of diabetic , muscle, metabolic and eating disorders |
| 10/28/2004 | US20040214172 Sheeplice, bovicola ovis, allergen treatment |
| 10/28/2004 | US20040214165 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 10/28/2004 | US20040214162 Porcine adenoviral sequences comprising gene regulatory elements for use as tools in heterologous gene delivery and expression systems and preparation of genetic vaccines |
| 10/28/2004 | US20040214158 Treatment of human papillomavirus (hpv)-infected cells |
| 10/28/2004 | US20040213836 DRUG DELIVERY; prolonging the time a pharmaceutical drug circulates in the blood of a subject, comprising: introducing into the subject's bloodstream a pharmaceutical composition comprising a liposome containing inventive compound |
| 10/28/2004 | US20040213797 Conjugates for the modulation of immune responses |
| 10/28/2004 | US20040213794 Mst1 modulation of apoptosis in cardiac tissue and modultors of Mst1 for treatment and prevention of cardiac disease |
| 10/28/2004 | US20040213790 VEGF-related protein |
| 10/28/2004 | US20040213783 modulation of CD200 or CD200R using a polyclonal antibody; a monoclonal antibody; a humanized antibody; an Fv, Fab, or F(ab')2 fragment; a blocking antibody; or a peptide mimetic of an antibody; autoimmune disorders |
| 10/28/2004 | US20040213780 Methods and compositions for treating polyglutamine expansion-associated disease |
| 10/28/2004 | US20040213769 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 10/28/2004 | US20040213764 Adenovirus replication-competent vectors expressing trail |
| 10/28/2004 | US20040213763 administering intravenously to the mammal an adenoviral vector comprising a DNA sequence encoding a leptin operably linked to a promoter and expressing the DNA sequence, for treating obesity in a mammal having a deficiency in functional leptin |
| 10/28/2004 | US20040213762 A viral vector containing a nucleic acid sequence encoding V3 polypeptide or a biologically active fragment of the V3 |
| 10/28/2004 | US20040213761 administering to a patient an effective amount of an agonist or antagonist of IL-23, for wound healing |
| 10/28/2004 | CA2522802A1 Biologically active substance-immobilized device |
| 10/28/2004 | CA2522082A1 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution |
| 10/28/2004 | CA2521839A1 Augmented cognitive training |
| 10/28/2004 | CA2521464A1 Irna conjugates |
| 10/28/2004 | CA2518529A1 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 10/28/2004 | CA2463487A1 Tumours treating combinations, compositions and methods |
| 10/28/2004 | CA2463464A1 Methods of treatment and compositions therefor |
| 10/27/2004 | EP1471146A2 A packaging cell line expressing for use in facilitating the development of high capacity adenoviral vectors |
| 10/27/2004 | EP1471143A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis |
| 10/27/2004 | EP1470826A1 Decoy-containing pharmaceutical compositions and method of using the same |
| 10/27/2004 | EP1470257A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470256A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE /GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470240A2 Methods and compositions for treating cardiovascular disease using 1682, 6169, 6193, 7771, 14395, 29002, 33216, 43726, 69292, 21656, 32427, 2402, 7747,1720, 9151, 60491, 1371, 7077, 33207, 1419, 18036, 16105, 38650, 14245, 58848, 1870, 25856, 32394, 3484, 345, 9252, 9135, 10532, 18610, 8165,2 |
| 10/27/2004 | EP1470239A2 Psoriasin expression by breast epithelial cells |
| 10/27/2004 | EP1470233A1 Adenoviral vectors for modulating the cellular activities associated with pods |
| 10/27/2004 | EP1470232A1 Physiologically regulated erythropoietin-expressing vector for the treatment of anaemia |
| 10/27/2004 | EP1470231A2 Methods of obtaining isoform specific expression in mammalian cells |
| 10/27/2004 | EP1470223A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 10/27/2004 | EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes |
| 10/27/2004 | EP1470161A1 Bispecific antibody dna constructs for intramuscular administration |
| 10/27/2004 | EP1470152A1 Peptides for increasing transfection efficiency |
| 10/27/2004 | EP1470148A2 Double-stranded oligonucleotides |
| 10/27/2004 | EP1470147A2 Telomere-encoding synthetic dna nanocircles, and their use for the elongation of telomere repeats |
| 10/27/2004 | EP1470145A2 Methods and materials for modulating p2x2 |
| 10/27/2004 | EP1470144A2 Oligonucleotides comprising alternating segments and uses thereof |
| 10/27/2004 | EP1469889A2 Ex-vivo gene therapy of diabetes using iap polypeptides |
| 10/27/2004 | EP1469888A2 Stem cell screening and transplantation therapy for hiv infection |
| 10/27/2004 | EP1469878A2 Fgfr agonists |
| 10/27/2004 | EP1469877A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 10/27/2004 | EP1469730A2 Methods and compositions for treating parkinson's disease |
| 10/27/2004 | EP1299126B1 Glutamic acid decarboxylase (gad) delivery system for treating neurodegenerative diseases |
| 10/27/2004 | EP1244457B1 Use of modulators of annexin for the manufacture of a medicament for the treatment and/or prevention of arthritis and arthritic diseases |
| 10/27/2004 | EP1204407B1 Implantable active ingredient depot |
| 10/27/2004 | EP1097209B1 Inhibition of alopecia |
| 10/27/2004 | EP1012603B1 Functional fragments of hiv-1 vpr protein and methods of using the same |
| 10/27/2004 | EP0998577B1 Conjugates of transporter peptides and nucleic acid analogs, and their use |
| 10/27/2004 | EP0977771A4 Sequence alterations using homologous recombination |
| 10/27/2004 | EP0832270B1 Cationic lipid:dna complexes for gene targeting |
| 10/27/2004 | EP0782862B1 Genetic material containing composition |
| 10/27/2004 | EP0763052B1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 10/27/2004 | EP0759992B1 Human papilloma virus inhibition by a hairpin ribozyme |
| 10/27/2004 | CN1541278A Novel molecular target for neurotoxicity |
| 10/27/2004 | CN1541269A Human protooncogene KG-zo and protein encoded therein |
| 10/27/2004 | CN1541265A Identification of DNA variant associated with adult type hypolactasia |
| 10/27/2004 | CN1539988A Gene target sequence box |
| 10/27/2004 | CN1539979A PGO of RNA1 carrier possessing labelling of green fluorescence protein and screening tag of resistance |
| 10/27/2004 | CN1539970A Heterophil neutral leucocyte factor alpha |
| 10/27/2004 | CN1539967A A group of nucleotide sequence for anti infection of coronavirus and preventing SARS and application |
| 10/27/2004 | CN1539849A Polypeptides encoded by haman lipase-like gene and compsns, and metods of utilizing same |
| 10/27/2004 | CN1539504A Bacterin of tabling gene of E type hepatitis virus |
| 10/27/2004 | CN1173039C Variant loxP sequences and application of the same |
| 10/27/2004 | CN1173033C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 10/26/2004 | US6809189 Apoptin-associating protein |
| 10/26/2004 | US6809182 Utlizing the varicella-zoster virus protein's ability to enter and exit eukaryotic cells for drug or secreting agent delivery |
| 10/26/2004 | US6809082 Synthetic transfection vectors |
| 10/26/2004 | US6808923 Episomally replicating lentiviral vectors |
| 10/26/2004 | US6808922 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 10/26/2004 | US6808905 Lentiviral vectors encoding clotting factors for gene therapy |
| 10/26/2004 | US6808880 Method for detecting polynucleotides encoding telomerase |
| 10/26/2004 | US6808878 Genes from the 20Q13 amplicon and their uses |
| 10/26/2004 | CA2263888C Methods and compositions for the detection of cervical cancer |
| 10/21/2004 | WO2004090145A2 Compounds and methods to enhance raav transduction |
| 10/21/2004 | WO2004090134A1 Oligoribonucleotide sequence homologous to a cdna region which codes for the human cd40 receptor and duplex oligoribonucleotides, vectors, pharmaceutical compositions and uses associated thereto |
| 10/21/2004 | WO2004090133A2 Method of rna cleavage and recombination |
| 10/21/2004 | WO2004090112A2 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 10/21/2004 | WO2004090108A2 Irna conjugates |
| 10/21/2004 | WO2004090107A2 Endosomolytic polymers |
| 10/21/2004 | WO2004090101A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 10/21/2004 | WO2004089439A2 Elective collection and banking of autologous peripheral blood stem cells |
| 10/21/2004 | WO2004089423A2 Pharmico-gene theraphy of epithelial sodium channel associated disoders |
| 10/21/2004 | WO2004089419A1 Lipid membrane structure containing anti-mt-mmp monoclonal antibody |
| 10/21/2004 | WO2004089417A1 Drug-enclosing multilayer structure particulate and process for producing the same |
| 10/21/2004 | WO2004089335A2 Non-aqueous single phase vehicles and formulations utilizing such vehicles |
| 10/21/2004 | WO2004089284A2 Targets for tumor growth inhibition |
| 10/21/2004 | WO2004089283A2 Compositions and methods for treating viral infections |
| 10/21/2004 | WO2004089189A2 Minimally-invasive imaging of viral gene therapy and presurgical applications thereof |
| 10/21/2004 | WO2004072305A3 Atlastin |
| 10/21/2004 | WO2004064856A3 Proteins involved in the regulation of energy homeostasis |
| 10/21/2004 | WO2004042025A3 Cell-specific adenovirus vector comprising ebv-specific promoter |
| 10/21/2004 | WO2003100081A3 Biologically active maleamic acid derivatives with labile amide bonds |
| 10/21/2004 | WO2003027266A3 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 10/21/2004 | WO2003025120A3 Clasp membrane proteins |